Veralto Corporation · VLTO · FY2025 Q2 · Calendar Q3 2025
Veralto raises EPS guidance as Water Quality leads Q2 growth
The current analysis supports a constructive but qualified view: resilient Water Quality demand, commercial execution, recurring offerings, and M&A support growth, while tariffs, China, currency, and PQI margin pressure temper the outlook.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about VLTO FY2025 Q2
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, management raised full-year EPS guidance, while the current analysis places greater emphasis on Water Quality growth, water-reuse and data-center demand, TraceGains and Esko cross-sell, and active but disciplined M&A.
Guidance delta
Raised: full-year adjusted EPS guidance moved to $3.72-$3.80 per share.
Key takeaways
- Q2 core sales grew 4.8% year over year and adjusted EPS rose 9.4% to $0.93.
- Water Quality led growth, including 11.4% growth in Western Europe.
- Management cited water reuse, data-center demand, commercial execution, and cross-sell as growth drivers.
- Free cash flow was $323 million, with continued emphasis on disciplined capex and acquisitions.
Management priorities
- Pursue targeted acquisitions in water technology and high-margin software.
- Expand water analytics and UV treatment for data-center and industrial customers.
- Invest in R&D and commercial architecture to deepen Veralto Enterprise System execution.
- Maintain disciplined capex while supporting free-cash-flow generation.
Follow VLTO with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 9, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Neutral | Neutral | Maintain | Oct 5, 2026 |
| Stifel | Buy | Buy | Maintain | Jul 30, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jul 30, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Jul 30, 2026 |
| BNP Paribas | Outperform | Outperform | Maintain | Jul 30, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 30, 2026 |
| Jefferies | Hold | Buy | Downgrade | Dec 10, 2025 |
| BMO Capital | Outperform | Outperform | Maintain | Nov 25, 2025 |
| Baird | Neutral | Neutral | Maintain | Jul 30, 2025 |
| TD Cowen | Hold | Hold | Maintain | Jul 30, 2024 |
| Goldman Sachs | Buy | Buy | Maintain | Jul 29, 2024 |
| Deutsche Bank | Hold | Hold | Maintain | Jul 29, 2024 |
| Vertical Research | Buy | Hold | Upgrade | Oct 16, 2023 |
Named analyst price targets
Upside is calculated against the persisted current price $97.48. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $106 | $94.68 | +8.7% | Oct 5, 2026 |
| UBS | Analyst unavailable | $104 | $94.18 | +6.7% | Jul 30, 2026 |
| Robert W. Baird | Analyst unavailable | $111 | $95.21 | +13.9% | Jul 30, 2026 |
| RBC Capital | Analyst unavailable | $109 | $94.8 | +11.8% | Jul 30, 2026 |
| Stifel Nicolaus | Analyst unavailable | $114 | $98.83 | +16.9% | Jul 30, 2026 |
| Stifel Nicolaus | Analyst unavailable | $111 | $93.81 | +13.9% | Jul 20, 2026 |
| Wolfe Research | Analyst unavailable | $109 | $92.12 | +11.8% | Jul 9, 2026 |
| Robert W. Baird | Michael Halloran | $103 | $89.47 | +5.7% | Apr 30, 2026 |
| Barclays | Analyst unavailable | $113 | $89.47 | +15.9% | Apr 30, 2026 |
| Stifel Nicolaus | Nathan Jones | $110 | $90.85 | +12.8% | Apr 14, 2026 |
| BMO Capital | Analyst unavailable | $108 | $92.81 | +10.8% | Feb 11, 2026 |
| UBS | Joshua Spector | $102 | $91.7 | +4.6% | Feb 6, 2026 |
| Stifel Nicolaus | Nathan Jones | $118 | $90.35 | +21.1% | Feb 5, 2026 |
| RBC Capital | Deane Dray | $102 | $89 | +4.6% | Feb 5, 2026 |
| Robert W. Baird | Michael Halloran | $108 | $91.41 | +10.8% | Feb 5, 2026 |
| Barclays | William Grippin | $117 | $91.41 | +20.0% | Feb 5, 2026 |
| Jefferies | Analyst unavailable | $105 | $98.34 | +7.7% | Dec 10, 2025 |
| BMO Capital | Analyst unavailable | $114 | $103.64 | +16.9% | Nov 25, 2025 |
| RBC Capital | Analyst unavailable | $111 | $100.26 | +13.9% | Oct 30, 2025 |
| Barclays | Analyst unavailable | $121 | $99.5 | +24.1% | Oct 30, 2025 |
| Barclays | William Grippin | $119 | $107.14 | +22.1% | Oct 6, 2025 |
| Barclays | Analyst unavailable | $120 | $107.06 | +23.1% | Sep 18, 2025 |
| Stifel Nicolaus | Analyst unavailable | $120 | $105.78 | +23.1% | Jul 30, 2025 |
| BMO Capital | John McNulty | $119 | $110.46 | +22.1% | Sep 30, 2024 |
| BMO Capital | John McNulty | $117 | $106.28 | +20.0% | Jul 29, 2024 |
| Stifel Nicolaus | Nathan Jones | $117 | $104.87 | +20.0% | Jul 29, 2024 |
| Robert W. Baird | Michael Halloran | $112 | $106.23 | +14.9% | Jul 29, 2024 |
| RBC Capital | Deane Dray | $108 | $106.25 | +10.8% | Jul 29, 2024 |
| Argus Research | John Eade | $110 | $97.27 | +12.8% | May 7, 2024 |
| BMO Capital | John McNulty | $101 | $92.4 | +3.6% | Apr 25, 2024 |
| RBC Capital | Deane Dray | $101 | $92.4 | +3.6% | Apr 25, 2024 |
| Goldman Sachs | Brian Lee | $104 | $89.46 | +6.7% | Mar 22, 2024 |
| RBC Capital | Deane Dray | $78 | $70.74 | -20.0% | Nov 3, 2023 |
Track every rating change on VLTO the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationVeralto Corporation is a global provider specializing in critical solutions across water quality management, brand protection, and packaging aesthetics. Its operations are structured into two primary divisions: Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment delivers advanced instrumentation and treatment technologies designed for the precise measurement, analysis, and purification of water. These solutions cater to a broad spectrum of applications, from residential and commercial settings to municipal systems, industrial processes, research facilities, and natural environments. Esteemed brands like Hach, Trojan Technologies, and ChemTreat fall under this segment, which also supplies essential chemical reagents, support services, and digital tools for comprehensive water management. The PQI segment focuses on enhancing product integrity and brand appeal.…
Historical context
All VLTO earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| DAL Delta Air Lines, Inc. | FY2026 Q3 · Calendar Q4 2026 | — | -1.7% | Delta Q3 2026: Strong Demand, With Costs Still in Focus |
| CTAS Cintas Corporation | FY2027 Q1 · Calendar Q3 2026 | +3.0% | -3.4% | Cintas raises FY2027 guidance as Q1 growth broadens |
| PAYX Paychex, Inc. | FY2027 Q1 · Calendar Q3 2026 | +1.5% | -8.8% | Paychex maintains FY27 outlook as PEO and AI momentum strengthen |
| FPS Forgent Power Solutions, Inc. | FY2026 Q4 · Calendar Q3 2026 | +4.3% | +9.5% | Forgent Power Solutions pairs record results with an aggressive FY27 buildout |
| CPRT Copart, Inc. | FY2026 Q4 · Calendar Q3 2026 | -8.7% | -2.6% | Copart pairs international growth with ACV investment amid higher costs |
| SUNB Sunbelt Rentals Holdings Inc | FY2027 Q1 · Calendar Q3 2026 | +19.2% | +5.9% | Sunbelt raises FY27 outlook as specialty rental demand accelerates |
Latest beats and misses
Who reports nextBeat on EPS
Get the VLTO recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:55.686058+00:00
- Polygon adjusted daily market bars · 2026-10-09T15:40:40.587653+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-09T15:40:40.584941+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-09. For educational purposes only; not investment advice.